The goal of this clinical research study is to learn if an antiepileptic (anti-seizure) treatment will prevent seizures in patients with brain tumors who have not yet had a seizure. Anti-seizure drugs are designed to decrease abnormal electrical activity in the brain that plays a role in developing seizures.
In this study, lacosamide will be used as an anti-seizure medication. Lacosamide will be compared to a placebo.
A placebo is not a drug. It looks like the study drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.
- Patients must be 18 years or older.
- Patients with histologically confirmed supratentorial high-grade glioma will be eligible for this protocol.
- All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.
Please contact us for full eligibility criteria.